Close
Help
Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Opthalmology

Get Updates

Opthalmology research articles, Opthalmology research article, Opthalmology journals, Opthalmology journal, Opthalmology articles, Research on Breast cancer, Opthalmology



Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • Interview with Clinical Medicine Insights: Oncology editorial board member Prof. M. Wasif Saif
  • - 18/Jun/2010
  • Interview with Biomarkers in Cancer editorial board member Dr Xiaofeng Zhou
  • - 18/Jun/2010
  • Interview with Microbiology Insights editorial board member Dr Viroj Wiwanitkit
  • - 18/Jun/2010
  • Interview with Cell & Tissue Transplantation & Therapy editorial board member Dr Terje Forslund
  • - 17/Jun/2010
  • Interview with Nutrition and Metabolic Insights editorial board member Prof.Abdulaziz I.AL-Othaimeen
  • - 17/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr Steven R. Myers
  • - 16/Jun/2010
  • Interview with Immunology and Immunogenetics Insights editorial board member Dr Robert Yarchoan
  • - 16/Jun/2010
  • Interview with International Journal of Tryptophan Research editorial board member Dr Martin Reuter
  • - 15/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Philip Crooke
  • - 15/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lalita Bharadwaj
  • - 15/Jun/2010
  • Interview with Integrative Medicine Insights editorial board member Dr Merrijoy Kelner
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Reproductive Health editorial board member Dr Lior Lowenstein
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Trauma and Intensive Medicine editorial board member Dr Michael Y. Wang
  • - 09/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lars Carlsen
  • - 09/Jun/2010
  • Interview with Evolutionary Bioinformatics editorial board member Dr Carsten Wiuf
  • - 04/Jun/2010
  • Interview with Translational Oncongenomics Editor in Chief Dr Michael Spinella
  • - 04/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Jimmy T. Efird
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Hardy Kornfeld
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Bruce S. Bochner
  • - 03/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Bradley J Erickson
  • - 03/Jun/2010
  • Biomarker Insights Editor in Chief co-author of Nature cover story
  • - 06/May/2010
  • Author interview with Dr Esther Uña Cidón
  • - 26/Apr/2010
  • Author interview with Dr Thomas Ostermann
  • - 24/Mar/2010
  • Author interview with Dr Yoshihito Yokoyama
  • - 11/Mar/2010

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
50
Articles published:
0
Comments:
23
Blog entries:

Journal: Ophthalmology and Eye Diseases

Editor in Chief: Joshua Cameron   |   Table of contents   |   26805 views
Get Updates
Abstract
Full-text PDF

Comparative Review of Ranibizumab versus Bevacizumab in the Treatment of Neovascular Age-related Macular Degeneration     (24/May/2010)


Age-related macular degeneration (AMD) is the leading cause of visual loss in the developed World in patients over age 55. Therapeutic advances in the dry (non-exudative) form of AMD have been very modest with a protective role demonstrated for supplemental anti-oxidant vitamin therapy in patients showing high risk characteristics for...


Abstract
Full-text PDF

Safety and Efficacy of Fixed Combination Travoprost-Timolol in the Lowering of Intraocular Pressure     (29/Apr/2010)


The fixed combination eye drop Duotrav is a combination of travoprost 0.004% and timolol maleate 0.5%. Both travoprost and timolol have been used separately for the treatment of glaucoma by lowering intraocular pressure. Multiple studies have demonstrated the efficacy and safety of the fixed combination travoprost/timolol for the treatment of...


Article: Early Involvement of Immune/Inflammatory Response Genes in Retinal Degeneration in DBA/2J Mice
Full-text PDFAbstract

Early Involvement of Immune/Inflammatory Response Genes in Retinal Degeneration in DBA/2J Mice     (11/Mar/2010)


Purpose: The DBA/2J (D2) mouse carries mutations in two of its genes, Tyrp1 and Gpnmb. These alterations result in the development of an immune response in the iris, leading to iris atrophy and pigment dispersion. The development of elevated intraocular pressure (IOP) in this model of glaucoma is considered to be a significant factor leading to the death of retinal ganglion cells (RGCs). Changes in gene expression in the retina have already been correlated with...


Abstract
Full-text PDF

Anti-inflammatory and Antihistaminic Study of a Unani Eye Drop Formulation     (10/Mar/2010)


The Unani eye drop is an ophthalmic formulation prepared for its beneficial effects in the inflammatory and allergic conditions of the eyes. In the present study, the Unani eye drop formulation was prepared and investigated for its anti-inflammatory and antihistaminic activity, using in vivo and in vitro experimental models respectively....


Article: Evolution of Cellular Inclusions in Bietti’s Crystalline Dystrophy
Full-text PDFAbstract

Evolution of Cellular Inclusions in Bietti’s Crystalline Dystrophy     (09/Mar/2010)


Bietti’s crystalline dystrophy (BCD) consists of small, yellow-white, glistening intraretinal crystals in the posterior pole, tapetoretinal degeneration with atrophy of the retinal pigment epithelium (RPE) and “sclerosis” of the choroid; in addition, sparking yellow crystals in the superficial marginal cornea are also found in many patients. BCD is inherited as an autosomal-recessive trait (4q35-tel) and usually has its onset in the third decade of life. This review focuses on the ultrastructure of cellular crystals and...


Abstract
Full-text PDF

The Use of Topical Tacrolimus 0.1% Skin Ointment for Anterior Segment Conditions: A Case Series     (23/Feb/2010)


Tacrolimus (FK 506) is a macrolactam derivative with immunomodulatory and anti-inflammatory activity. Topical tacrolimus 0.03% has been used for inflammatory conditions of the anterior segment. This article adds to the literature on the off-license application of tacrolimus ointment, by describing the safe and effective use of the higher strength of...


Abstract
Full-text PDF

Spectral Domain OCT Documented Resolution of Pseudophakic Cystoid Macular Edema after Intravitreal Triamcinolone     (03/Feb/2010)


Cystoid macular edema (CME) is an important cause of visual loss after cataract surgery. Treatment is usually with topical anti-inflammatory agents, with anti-vascular endothelial growth factor agents and steroids used intravitreally in resistant cases. Even though time-domain Stratus OCT can quantify the macular thickness, it cannot prognosticate visual outcomes due...


Article: A Case of Protruding Eyeballs and Diminishing Vision
Full-text PDFAbstract

A Case of Protruding Eyeballs and Diminishing Vision     (20/Jan/2010)


This case report discusses issues related to a 56-year-old man from Bangalore who presented with complaints of a gradual protrusion of his eyeballs along with diminishing vision for the previous month. The approach to diagnosis and management issues around this unusual presentation is discussed.


Article: Stratification of Antigen-presenting Cells within the Normal Cornea
Full-text PDFAbstract

Stratification of Antigen-presenting Cells within the Normal Cornea     (25/Nov/2009)


The composition and location of professional antigen presenting cells (APC) varies in different mucosal surfaces. The cornea, long considered an immune-privileged tissue devoid of APCs, is now known to host a heterogeneous network of bone marrow-derived cells. Here, we utilized transgenic mice that express enhanced green fluorescent protein (EGFP) from the CD11c promoter (pCD11c) in conjunction with immunohistochemical staining to demonstrate an interesting stratification of APCs within non-inflamed murine corneas. pCD11c+ dendritic cells (DCs)...


Article: Stratification of Antigen-presenting Cells within the Normal Cornea
Full-text PDFAbstract

Stratification of Antigen-presenting Cells within the Normal Cornea     (25/Nov/2009)


The composition and location of professional antigen presenting cells (APC) varies in different mucosal surfaces. The cornea, long considered an immune-privileged tissue devoid of APCs, is now known to host a heterogeneous network of bone marrow-derived cells. Here, we utilized transgenic mice that express enhanced green fluorescent protein (EGFP) from the CD11c promoter (pCD11c) in conjunction with immunohistochemical staining to demonstrate an interesting stratification of APCs within non-inflamed murine corneas. pCD11c+ dendritic cells (DCs)...


Abstract
Full-text PDF

Retinal Ganglion Cell Loss in Diabetes Associated with Elevated Homocysteine     (17/Nov/2009)


A number of studies have suggested that homocysteine may be a contributing factor to development of retinopathy in diabetic patients based on observed correlations between elevated homocysteine levels and the presence of retinopathy. The significance of such a correlation remains to be determined, and potential mechanisms by which homocysteine might...


Abstract
Full-text PDF

Anterior Chamber-Associated Immune Deviation (ACAID): An Acute Response to Ocular Insult Protects from Future Immune-Mediated Damage?     (17/Nov/2009)


The “immune privilege” that inhibits immune defense mechanisms that could lead to damage to sensitive ocular tissue is based on the expression of immunosuppressive factors on ocular tissue and in ocular fluids. In addition to this environmental protection, the injection of antigen into the anterior chamber or infection in the...


Abstract
Full-text PDF

Pharmacokinetics of Stereoisomeric Dipeptide Prodrugs of Acyclovir Following Intravenous and Oral Administrations in Rats: A Study Involving In vivo Corneal Uptake of Acyclovir Following Oral Dosing     (21/Oct/2009)


Objective: To delineate the plasma pharmacokinetics and determine the corneal uptake of valine based stereoisomeric dipeptide prodrugs of acyclovir (ACV) in rats. Methods: Male Sprague-Dawley rats were used for the study. Pharmacokinetics of ACV, L-valine-acyclovir (LACV), L-valine- D-valine-acyclovir (LDACV) and D-valine-L-valine acyclovir (DLACV) prodrugs were delineated. These compounds were administered...


Abstract
Full-text PDF

The Effects of Fetal Surgery on Retinopathy of Prematurity Development     (01/Oct/2009)


Background: Fetal surgery is selectively offered for severe or life-threatening fetal malformations. These infants are often born prematurely and are thus at risk for retinopathy of prematurity (ROP). It is not known whether fetal surgery confers an increased risk of developing severe ROP relative to published rates in standard premature...


Abstract
Full-text PDF

Exudative Age-Related Macular Degeneration: Current Therapies and Potential Treatments     (27/Aug/2009)


Strategies for preventing vision loss in patients with neovascular age-related macular degeneration (ARMD) have evolved over the past decade. Whereas earlier treatments were based on thermal destruction of choroidal neovascularization (CNV), new therapies rely on targeted pharmacologic approaches to reduce the harmful effects of CNV treatment. For the first time...


Article: Diabetes Accelerates Retinal Neuronal Cell Death In A Mouse Model of Endogenous Hyperhomocysteinemia
Full-text PDFAbstract

Diabetes Accelerates Retinal Neuronal Cell Death In A Mouse Model of Endogenous Hyperhomocysteinemia     (29/Jul/2009)


Hyperhomocysteinemia has been implicated in visual dysfunction. We reported recently that mice with endogenous hyperhomocysteinemia, due to mutation of the cystathionine-β-synthase (cbs) gene, demonstrate loss of neurons in the retinal ganglion cell (RGC) layer and other retinal layers as homocysteine levels increase. Some clinical studies implicate hyperhomocysteinemia in the pathogenesis of diabetic retinopathy, which is also characterized by RGC loss. The present study used cbs+/- mice to determine whether modest elevation of plasma homocysteine, in...


Article: Exophthalmos as a Presenting Manifestation of Limited Wegener’s Granulomatosis in a Patient with Prior Graves’ Disease
Full-text PDFAbstract

Exophthalmos as a Presenting Manifestation of Limited Wegener’s Granulomatosis in a Patient with Prior Graves’ Disease     (30/Jun/2009)


Wegener’s granulomatosis is a granulomatous necrotizing vasculitis characterized by its predilection to affect the upper and lower respiratory tracts and kidneys. Ocular manifestations such as keratitis, conjunctivitis, scleritis, episcleritis, nasolacrimal duct obstruction, uveitis, retroorbital pseudotumor with proptosis retinal vessel occlusion, and optic neuritis have all been described. We present a case of limited Wegener’s granulomatosis presenting with proptosis. A 57 year old woman with a history of Graves’ disease 20 yrs ago, presented to her ophthalmologist...


Abstract
Full-text PDF

Pharmacotherapy of Retinal Diseases with Ranibizumab     (16/Apr/2009)


Daniel F. Kiernan1, Theodore K. Lin1, Veeral Sheth1 and Rama D. Jager1,21University of Chicago Hospitals, Section of Ophthalmology and Visual Sciences, Department of Surgery, 5841 S Maryland Ave—MC 2114, Chicago, IL 60637. 2University Retina and Macula Associates, 6320 W, 159th St., Suites A and D, Oak Forest, IL 60452.AbstractThe development...


Article: A Case of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome with High ASLO Titer
Full-text PDFAbstract

A Case of Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome with High ASLO Titer     (09/Apr/2009)


Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare autoimmune disease and the pathogenesis is still unknown. We report a case of TINU syndrome with high ASLO titer. Uveitis improved and urine β2-MG normalized with low dose systemic predonisolone and cyclosporin A. The high ASLO titer in early phase suggested that streptococcal infection might have triggered TINU syndrome. Lymphocyte phenotypes normalized after treatment with low dose systemic predonisolone and cyclosporin A.


Abstract
Full-text PDF

Introductory Editorial (Ophthalmology and Eye Diseases)     (16/Jan/2009)


Introductory Editorial by Dr Joshua Cameron, Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, U.S.A.